PolarityTE to Report Q2 2022 Financial Results on August 11, 2022

Rhea-AI Summary

PolarityTE (NASDAQ: PTE) announced it will release its financial results for the quarter ended June 30, 2022, on August 11, 2022, at approximately 4:05 p.m. ET. A conference call will follow at 4:30 p.m. ET, accessible by dialing 1-800-207-0148 with passcode 893469. The company is developing regenerative tissue products, including SkinTE®, which is under FDA review. The earnings call will be available via a webcast. Investors can access a replay of the call for 30 days post-event on PolarityTE's website.

News Market Reaction – PTE

+0.75%

+0.75% Session move

In the trading session that priced this news, PTE gained 0.75%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SALT LAKE CITY, Aug. 1, 2022 /PRNewswire/ -- PolarityTE, Inc. (NASDAQ: PTE) today announced that it will report results for the quarter ended June 30, 2022, by press release on Thursday, August 11, 2022, at approximately 4:05 p.m. Eastern Time.

In addition, the Company will host a conference call and webcast with Q&A on August 11, 2022, at 4:30 p.m. Eastern Time. The conference call can be accessed by calling 1-800-207-0148 with passcode 893469 and referencing "PolarityTE Second Quarter 2022 Business Update and Financial Results." A webcast of the conference call can be accessed by using the link below.

Earnings Call Webcast - CLICK HERE

A replay of the earnings conference call will be available for 30 days beginning approximately one hour after the conclusion of the call and can be found by visiting PolarityTE's website at https://www.polarityte.com/news-media/events, or by clicking on the link above.

About PolarityTE^®

PolarityTE, Inc., headquartered in Salt Lake City, Utah, is a biotechnology company developing regenerative tissue products. PolarityTE's first regenerative tissue product is SkinTE^®. PolarityTE has an open investigational new drug application (IND) for SkinTE^® with the U.S. Food and Drug Administration (FDA) and is now pursuing the first of two pivotal studies on SkinTE^® needed to support a biologics license application (BLA) for a chronic cutaneous ulcer indication. SkinTE^® is available for investigational use only. Learn more at www.PolarityTE.com.

POLARITYTE, the POLARITYTE logo, SKINTE, and WHERE SELF REGENERATES SELF are registered trademarks of PolarityTE, Inc.

CONTACTS

Investors:
PolarityTE Investor Relations
ir@PolarityTE.com
(385) 831-5284

Media:
David Schull or Ignacio Guerrero-Ros
David.schull@russopartnersllc.com 
Ignacio.guerrero-ros@russopartnersllc.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/polarityte-to-report-q2-2022-financial-results-on-august-11-2022-301596394.html

SOURCE PolarityTE, Inc.

FAQ

When will PolarityTE report its Q2 2022 financial results?

PolarityTE will report its Q2 2022 financial results on August 11, 2022.

What time is the Q2 2022 earnings call for PolarityTE?

The Q2 2022 earnings call will be held on August 11, 2022, at 4:30 p.m. ET.

How can I access the earnings call for PolarityTE?

You can access the earnings call by calling 1-800-207-0148 and using passcode 893469.

What is SkinTE by PolarityTE?

SkinTE® is PolarityTE's first regenerative tissue product currently under FDA review for use in chronic cutaneous ulcers.

Will there be a replay of the earnings call for PolarityTE?

Yes, a replay of the earnings call will be available for 30 days on PolarityTE's website.